C Chavis
Overview
Explore the profile of C Chavis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonnans C, Chanez P, Chavis C
Allergy
. 2004 Sep;
59(10):1027-41.
PMID: 15355460
Arachidonic acid metabolism represents an important source of mediators with ambivalent actions. Among these, lipoxins (LXs) are the first agents identified and recognized as anti-inflammatory endogenous lipid mediators, which are...
2.
Romagnoli M, Vachier I, Tarodo de la Fuente P, Meziane H, Chavis C, Bousquet J, et al.
Eur Respir J
. 2002 Dec;
20(6):1370-7.
PMID: 12503691
Despite full effective treatment, asthmatic patients often present with poorly controlled asthma. Airway eosinophilia is associated with asthma, but its relationship with asthma control is still undetermined. To investigate the...
3.
Vachier I, Chanez P, Bonnans C, Godard P, Bousquet J, Chavis C
Biochem Biophys Res Commun
. 2002 Jan;
290(1):219-24.
PMID: 11779156
Eicosanoids have been historically involved in the pathogenesis of various inflammatory diseases. Lipoxins (LXs) and epi-LXs show physiological effects relevant to inflammation regulation. In this study, we focused on LX...
4.
Vachier I, Chavis C, Majori M, Farce M, Bousquet J, Godard P, et al.
J Allergy Clin Immunol
. 2001 May;
107(5):824-31.
PMID: 11344349
Background: Human blood polymorphonuclear cells, which biosynthesize eicosanoids from the 5-lipoxygenase (5-LO) pathway, are likely to be involved in asthma, in which glucocorticoids represent the first line of therapy. Their...
5.
Chavis C, Vachier I, Godard P, Bousquet J, Chanez P
Thorax
. 2000 Sep;
55 Suppl 2:S38-41.
PMID: 10992555
No abstract available.
6.
Chavis C, Fraissinet L, Chanez P, Thomas E, Bousquet J
Anal Biochem
. 1999 Jun;
271(1):105-8.
PMID: 10361015
No abstract available.
7.
Chavis C, Vachier I, Bousquet J, Godard P, Chanez P
Biochem Pharmacol
. 1998 Oct;
56(4):535-41.
PMID: 9763231
The aim of this study was to investigate eicosanoid metabolism by human peripheral blood monocytes (PBM) from steroid-dependent asthmatic patients as compared to control subjects and untreated asthmatic patients. Eicosanoid...
8.
Chavis C, van Vyve T, Chanez P, Farce M, Bousquet J, Michel F, et al.
Allergy
. 1997 May;
52(5):589-92.
PMID: 9201374
Cysteinyl leukotrienes (C-LTs) are local inflammatory mediators involved in bronchial asthma. Seventeen asthmatic patients (FEV1 ranging from 41 to 99.8% of predicted values) and 11 healthy subjects were studied. The...
9.
Winum J, Kamal M, Defacque H, Commes T, Chavis C, Lucas M, et al.
Farmaco
. 1997 Jan;
52(1):39-42.
PMID: 9181680
Homoretinoic and bishomoretinoic acid have been synthesized. Fast reaction under ultrasonic activation (Wolff rearrangement, saponification) produced compounds in high yields. Only the bishomo analogue exhibits a significative activity alone and...
10.
Chavis C, Vachier I, Chanez P, Bousquet J, Godard P
J Exp Med
. 1996 Apr;
183(4):1633-43.
PMID: 8666921
5-Lipoxygenase activation of human blood polymorphonuclear cells (PMN) from asthmatic patients (asthmatics) was studied to investigate whether differences may exist with healthy subjects (controls). The respective cell capacities to produce...